Attached files
| file | filename |
|---|---|
| 10-Q - 10Q AT MARCH 31, 2010 - INNOVUS PHARMACEUTICALS, INC. | nohor0310_10q.htm |
| EX-32.1 - EXHIBIT 32.1 - INNOVUS PHARMACEUTICALS, INC. | nohor031010q32_1.htm |
| EX-31.1 - EXHIBIT 31.1 - INNOVUS PHARMACEUTICALS, INC. | nonor031010q31_1.htm |
| EX-31.2 - EXHIBIT 31.2 - INNOVUS PHARMACEUTICALS, INC. | nohor031010q31_2.htm |
EXHIBIT 32.2
Section 1350 Certification
In connection with the Report of North Horizon, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2010 as filed with the Securities and Exchange Commission (the “Report”), I, Wallace Boyack, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.
|
|
Date: May 12, 2010
|
By:
|
/s/Wallace Boyack
|
|
|
Wallace Boyack
|
|||
|
Chief Financial Officer, principal financial and accounting officer
|